<?xml version="1.0" ?>
<document id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5">
  <chunk id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c0" text="The importance of mouse models to define immunovirologic determinants of progressive multifocal leukoencephalopathy">
    <entity charOffset="73-115" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c0.e0" ontology_id="DOID_643" text="progressive multifocal leukoencephalopathy" type="disease"/>
  </chunk>
  <chunk id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1" text="Progressive multifocal leukoencephalopathy (PML) is a severely debilitating and often fatal demyelinating disease of the central nervous system (CNS) in immunosuppressed individuals caused by JC polyomavirus (JCV), a ubiquitous human pathogen. Demyelination results from lytically infected oligodendrocytes, whose clearance is impaired in the setting of depressed JCV-specific T cell-mediated CNS surveillance. Although mutations in the viral capsid and genomic rearrangements in the viral non-coding region appear to set the stage for PML in the immunosuppressed population, mechanisms of demyelination and CNS antiviral immunity are poorly understood in large part due to absence of a tractable animal model that mimics PML neuropathology in humans. Early studies using mouse polyomavirus (MPyV) in T cell-deficient mice demonstrated productive viral replication in the CNS and demyelination; however, these findings were confounded by spinal cord compression by virus-induced vertebral bone tumors. Here, we review current literature regarding animal models of PML, focusing on current trends in antiviral T cell immunity in non-lymphoid organs, including the CNS. Advances in our understanding of polyomavirus lifecycles, viral and host determinants of persistent infection, and T cell-mediated immunity to viral infections in the CNS warrant revisiting polyomavirus CNS infection in the mouse as a bona fide animal model for JCV-PML.">
    <entity charOffset="0-42" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e0" ontology_id="DOID_643" text="Progressive multifocal leukoencephalopathy" type="disease"/>
    <entity charOffset="44-47" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e1" ontology_id="DOID_643" text="PML" type="disease"/>
    <entity charOffset="92-113" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e2" ontology_id="DOID_3213" text="demyelinating disease" type="disease"/>
    <entity charOffset="106-113" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e3" ontology_id="DOID_4" text="disease" type="disease"/>
    <entity charOffset="536-539" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e4" ontology_id="DOID_643" text="PML" type="disease"/>
    <entity charOffset="612-621" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <entity charOffset="722-725" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e6" ontology_id="DOID_643" text="PML" type="disease"/>
    <entity charOffset="1064-1067" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e7" ontology_id="DOID_643" text="PML" type="disease"/>
    <entity charOffset="1099-1108" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" ontology_id="CHEBI_22587" text="antiviral" type="chemical"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e0" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p0" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e0" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p1" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e1" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p2" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e1" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p3" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e2" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p4" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e2" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p5" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e3" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p6" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e3" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p7" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e4" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p8" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e4" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p9" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e6" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p10" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e5" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e7" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p11" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e6" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p12" relation="true"/>
    <pair e1="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e7" e2="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.e8" id="815b5e537a3e7bdb7d5c7c7cd51181b9b2e245c5.c1.p13" relation="true"/>
  </chunk>
</document>
